Intravitreal dexamethasone implants versus intravitreal anti-VEGF treatment in treating patients with retinal vein occlusion: a meta-analysis

BACKGROUND: Retinal vein occlusion (RVO) is a common retinal venous disorder that causes vision loss. No specific therapy has been developed. Controversy exists regarding two treatments: intravitreal dexamethasone implants and anti-vascular endothelial growth factor (VEGF). The goal of this study is...

Descripción completa

Detalles Bibliográficos
Autores principales: Gao, Lixiong, Zhou, Lijun, Tian, Chunyu, Li, Na, Shao, Weiyang, Peng, Xiujun, Shi, Qian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6325672/
https://www.ncbi.nlm.nih.gov/pubmed/30621640
http://dx.doi.org/10.1186/s12886-018-1016-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6325672/
https://www.ncbi.nlm.nih.gov/pubmed/30621640
http://dx.doi.org/10.1186/s12886-018-1016-7

Ejemplares similares